Shanghai ZJ Bio-Tech CoSHSE:688317 +1.53%65 3-Year ROIIC % is 225.26 as of Dec. 2025, which is 147% above its 10-year median of 91.38. GuruFocus rates SHSE:688317 with a GF Score™ of 65/100 and a GF Value™ of ¥9.89 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Shanghai ZJ Bio-Tech Co ranks better than 94.12% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Shanghai ZJ Bio-Tech Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 225.26%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Shanghai ZJ Bio-Tech Co's 3-Year ROIIC % or its related term are showing as below:
SHSE:688317's 3-Year ROIIC % is ranked better than 94.12% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 1.78
vs SHSE:688317: 225.26
Shanghai ZJ Bio-Tech Co (SHSE:688317) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Shanghai ZJ Bio-Tech Co 3-Year ROIIC % Related Terms
Shanghai ZJ Bio-Tech Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688317 vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Shanghai ZJ Bio-Tech Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai ZJ Bio-Tech Co 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai ZJ Bio-Tech Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Shanghai ZJ Bio-Tech Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Shanghai ZJ Bio-Tech Co (SHSE:688317) has a 3-Year ROIIC % of 225.26 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. This is 147% above median its historical median of 91.38. According to the industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #47 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 5.9%.
Is Shanghai ZJ Bio-Tech Co's 3-Year ROIIC % too high?
Shanghai ZJ Bio-Tech Co's current 3-Year ROIIC % of 225.26 is 147% above median its 10-year median of 91.38. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.78. Shanghai ZJ Bio-Tech Co's value of 225.26 is 12555.1% above this industry median. Based on the distribution chart, Shanghai ZJ Bio-Tech Co ranks #47 out of 799 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai ZJ Bio-Tech Co has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai ZJ Bio-Tech Co's 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #47 out of 799 companies for 3-Year ROIIC %. This places Shanghai ZJ Bio-Tech Co in the top 6% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.78. Shanghai ZJ Bio-Tech Co's value of 225.26 is 12555.1% above this benchmark. While the company's 10-year median is 91.38 vs. the industry median of 1.78, Shanghai ZJ Bio-Tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.78, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai ZJ Bio-Tech Co's current 3-Year ROIIC % of 225.26 is 12555.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai ZJ Bio-Tech Co's current 3-Year ROIIC % is 225.26, which is 147% above median its own 10-year median of 91.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai ZJ Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co (SHSE:688317) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.89, compared to a current price of ¥15.97 — trading 61.5% above its estimated fair value. The current 3-Year ROIIC % is 225.26, which is 147% above median its 10-year median of 91.38 and 12555.1% above the Medical Devices & Instruments industry median of 1.78. Shanghai ZJ Bio-Tech Co's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Shanghai ZJ Bio-Tech Co (SHSE:688317), the current 3-Year ROIIC % is 225.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai ZJ Bio-Tech Co (SHSE:688317) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co stock appears to be overvalued.
The current stock price of ¥15.97 is trading 61.5% above its estimated GF Value™ of ¥9.89.
GuruFocus considers Shanghai ZJ Bio-Tech Co to be Significantly Overvalued.
Key valuation signals for SHSE:688317:
3-Year ROIIC %: 225.26 (147% above median its 10-year median of 91.38)
GF Value™: ¥9.89 vs. price of ¥15.97 (61.5% above fair value)
Industry Position: 12555.1% above the Medical Devices & Instruments median (#47 of 799)
No single metric tells the full story. See the SHSE:688317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
65GF Score
Get the complete analysis for SHSE:688317
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688317 has been successfully added to your 
